Two Potential Drug Pipeline "Disruptors" to Watch

Two Potential Drug Pipeline "Disruptors" to Watch

Kalorama's new report isolates potential drug pipeline "disruptors," new pharmaceuticals that could change future market leadership because of their effectiveness in a given disease area. In this article we look at two of them, a drug pipeline candidate in asthma and a drug pipeline candidate in lymphoma.

  • by Bruce Carlson
  • May 23 2017


SHERLOCK System Brings Potential for CRISPR Gene-Editing in Diagnostics

SHERLOCK System Brings Potential for CRISPR Gene-Editing in Diagnostics

CRISPR technology has already emerged as a revolutionary technology that is changing life science research and has the potential to dramatically change medicine. Now, CRISPR gene-editing in diagnostic testing is possible, with a new diagnostic platform called Specific High-Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK).

  • by Bruce Carlson
  • May 16 2017


Virtual Reality in Healthcare - Nearly a Billion-Dollar U.S. Market

Virtual Reality in Healthcare - Nearly a Billion-Dollar U.S. Market

There's a $976 million dollar market for virtual reality in healthcare, according to a new Kalorama Information report. VR and augmented reality (AR) are helping to train surgeons, enable remote professional consults, steer robots and even treat pain.

  • by Emil Salazar
  • May 11 2017


Virtual Anatomy Develops into a Major Tool in Medical Education

Virtual Anatomy Develops into a Major Tool in Medical Education

Cadavers are an invaluable resource for medical education in the United States, but require selfless donation on the part of thousands, billions of dollars in associated anatomy lab costs, and careful collaboration on the part of medical students and residents. . An emerging solution has been virtual anatomy with the use of highly complex, interactive representations of the human body and its systems.


AHCA and Retail Clinics: Assessing the Impact

AHCA and Retail Clinics: Assessing the Impact

The retail clinics market and the number of locations could be affected by the proposed and House-passed American Healthcare Act (AHCA). But it's also possible change could be limited, according to Kalorama Information, with a decade of studies on walk-in store clinics.

  • by Bruce Carlson
  • May 2 2017


Liquid Biopsy Market: Investors Are Noticing

Liquid Biopsy Market: Investors Are Noticing

Recent events demonstrate that non-Invasive cancer screening known remains attractive and a large liquid biopsy market is projected, according to Kalorama Information's latest report. Interest is high in non-invasive methods to screen for cancer. While much of this interest is focused on blood-based cancer screening tests, other types of non-invasive screening tests are also attracting attention. cell-free DNA is a key liquid biopsy technology, and we discuss the market for these tests in this article.

  • by Bruce Carlson
  • May 2 2017
  • IVD


Back On: Abbott to Acquire Alere, Creating Clear #2 in IVD Industry

Back On: Abbott to Acquire Alere, Creating Clear #2 in IVD Industry

We said last year it would create a POC juggernaut in the IVD market and allow enhance Abbott's competitiveness in infectious disease testing, but the combination of Alere and Abbott was stalled in the courts and with tension between the two companies. Now, to the surprise of many, the deal is back on. Our in vitro diagnostics market reports detail the share of the market that both companies have, both in sales and in test volume.

  • by Bruce Carlson
  • April 28 2017
  • EMR


The State of the EMR Market in 2017

The State of the EMR Market in 2017

The now $28 billion-dollar EMR market is undergoing changes, according to a new report from Kalorama Information. Physician adoption of medical records s is high but usage of EHR might be limited. Providers are switching vendors. And a new administration, no fans of EMR payment schemes and use standards, may bring regulation and payment changes. This article also addresses market share in the electronic medical records market and top EHR vendors.


Promise of Fast Growth Propels Molecular Technologies in Fighting Infections

Promise of Fast Growth Propels Molecular Technologies in Fighting Infections

Molecular infectious disease tests detect active and latent patient infections by targeting genetic sequences specific to pathogens, typically bacteria or viruses, but also fungi and parasites. Tests that utilize these methods experience faster revenue growth and will compete better on the world market, according to Kalorama's recent study on the molecular infectious disease testing market.


Want a Vision of The POC Diagnostics Market in the Future? Look no Further Than Star Trek

Want a Vision of The POC Diagnostics Market in the Future?   Look no Further Than Star Trek

Inspired by Qualcom's prize, two innovative POC products won a competition to develop Gene Roddenberry-influenced diagnostic devices. These devices may point to the future of the POC diagnostics market.